Pauline Merrill to Humans
This is a "connection" page, showing publications Pauline Merrill has written about Humans.
Connection Strength
0.355
-
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema. Am J Ophthalmol. 2023 04; 248:16-23.
Score: 0.048
-
Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial. Ocul Immunol Inflamm. 2023 Oct; 31(8):1579-1586.
Score: 0.044
-
Efficacy of Adalimumab in Non-Infectious Uveitis Across Different Etiologies: A Post Hoc Analysis of the VISUAL I and VISUAL II Trials. Ocul Immunol Inflamm. 2021 Nov 17; 29(7-8):1569-1575.
Score: 0.041
-
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program. Ophthalmology. 2020 10; 127(10):1405-1415.
Score: 0.040
-
CYSTOID MACULAR EDEMA SECONDARY TO RITUXIMAB. Retin Cases Brief Rep. 2019 Spring; 13(2):111-114.
Score: 0.037
-
SPOTTED FEVER GROUP RICKETTSIA RETINITIS IN A TRAVELER TO AFRICA. Retin Cases Brief Rep. 2016; 10(1):89-92.
Score: 0.030
-
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE. Clin Exp Ophthalmol. 2022 01; 50(1):23-30.
Score: 0.011
-
First Case of Subretinal Ocular Angiostrongyliasis Associated with Retinal Detachment in the United States. Hawaii J Health Soc Welf. 2021 11; 80(11 Suppl 3):40-44.
Score: 0.011
-
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). Br J Ophthalmol. 2022 08; 106(8):1139-1144.
Score: 0.011
-
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. Ophthalmology. 2021 06; 128(6):899-909.
Score: 0.010
-
Anterior uveitis in patients with spondyloarthropathies in a single US academic center: a retrospective study. Rheumatol Int. 2019 Sep; 39(9):1607-1614.
Score: 0.010
-
Assessing the Precision of ICD-10 Codes for Uveitis in 2 Electronic Health Record Systems. JAMA Ophthalmol. 2018 10 01; 136(10):1186-1190.
Score: 0.009
-
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies. Ophthalmology. 2018 12; 125(12):1984-1993.
Score: 0.009
-
Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA). Ophthalmology. 2016 11; 123(11):2413-2423.
Score: 0.008
-
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016 Sep 17; 388(10050):1183-92.
Score: 0.008
-
HLA-A29-POSITIVE BIRDSHOT CHORIORETINOPATHY IN AN AFRICAN AMERICAN PATIENT. Retin Cases Brief Rep. 2016; 10(3):201-4.
Score: 0.007
-
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol. 2014 Jan; 98(1):99-103.
Score: 0.006
-
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm. 2012 Apr; 20(2):104-12.
Score: 0.006
-
Diagnostic and therapeutic challenges. Acute retinal necrosis syndrom. Retina. 2008 Apr; 28(4):660-4.
Score: 0.004
-
Magnetic resonance imaging of diffuse cerebral vasculitis associated with acute retinal necrosis. Arch Ophthalmol. 2004 Nov; 122(11):1719-20.
Score: 0.003